R01DK092485/DK/NIDDK NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2011	1
2012	1
2013	3
2014	5
2015	7
2016	1
2022	0

1

The renaissance of corticotropin therapy in proteinuric nephropathies.

Gong R. Gong R. Nat Rev Nephrol. 2011 Dec 6;8(2):122-8. doi: 10.1038/nrneph.2011.190. Nat Rev Nephrol. 2011. PMID: 22143333 Free PMC article. Review.

2

Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.

Brem AS, Gong R. Brem AS, et al. Clin Sci (Lond). 2015 May;128(9):527-35. doi: 10.1042/CS20140432. Clin Sci (Lond). 2015. PMID: 25671776 Free PMC article. Review.

3

Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.

Liu Z, Gong R. Liu Z, et al. Am J Kidney Dis. 2015 Nov;66(5):846-56. doi: 10.1053/j.ajkd.2015.06.026. Epub 2015 Aug 10. Am J Kidney Dis. 2015. PMID: 26271146 Free PMC article. Review.

4

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Li C, Ge Y, Dworkin L, Peng A, Gong R. Li C, et al. J Pathol. 2016 May;239(1):23-35. doi: 10.1002/path.4692. Epub 2016 Mar 16. J Pathol. 2016. PMID: 26876299 Free PMC article.

5

Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms.

Si J, Ge Y, Zhuang S, Wang LJ, Chen S, Gong R. Si J, et al. Kidney Int. 2013 Apr;83(4):635-46. doi: 10.1038/ki.2012.447. Epub 2013 Jan 16. Kidney Int. 2013. PMID: 23325074 Free PMC article.

6

Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.

Xu W, Ge Y, Liu Z, Gong R. Xu W, et al. J Biol Chem. 2015 Jan 16;290(3):1348-63. doi: 10.1074/jbc.M114.593830. Epub 2014 Dec 2. J Biol Chem. 2015. PMID: 25468908 Free PMC article.

7

Delayed administration of a single dose of lithium promotes recovery from AKI.

Bao H, Ge Y, Wang Z, Zhuang S, Dworkin L, Peng A, Gong R. Bao H, et al. J Am Soc Nephrol. 2014 Mar;25(3):488-500. doi: 10.1681/ASN.2013040350. Epub 2014 Jan 9. J Am Soc Nephrol. 2014. PMID: 24408869 Free PMC article.

8

Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.

Wang Z, Bao H, Ge Y, Zhuang S, Peng A, Gong R. Wang Z, et al. Br J Pharmacol. 2015 Feb;172(3):895-909. doi: 10.1111/bph.12952. Epub 2014 Dec 15. Br J Pharmacol. 2015. PMID: 25262943 Free PMC article.

9

Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.

Bao H, Ge Y, Peng A, Gong R. Bao H, et al. Kidney Int. 2015 Jun;87(6):1176-90. doi: 10.1038/ki.2014.428. Epub 2015 Jan 28. Kidney Int. 2015. PMID: 25629551 Free PMC article.

10

Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C.

Jiang Y, Bao H, Ge Y, Tang W, Cheng D, Luo K, Gong G, Gong R. Jiang Y, et al. Gut. 2015 Jan;64(1):168-79. doi: 10.1136/gutjnl-2013-306043. Epub 2014 May 8. Gut. 2015. PMID: 24811996 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results